Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Kollmeier
    Kollmeier
  2. Yamada
    Yamada
  3. Zaider
    Zaider
  4. Damato
    Damato
  5. Zhang
    Zhang
  6. Dauer
    Dauer
  7. McBride
    McBride
  8. Gorovets
    Gorovets
  9. Alektiar
    Alektiar
  10. Bains
    Bains

Groups

  1. Medical Physics (37)
  2. Radiation Oncology, Department of (37)
  3. Survivorship Research (37)
  4. Radiotherapy Physics Service (26)
  5. GDMT, Radiation Oncology (19)
  6. Gynecology Disease Management Team (19)
  7. Sloan Kettering Institute Postdocs (10)
  8. Biostatistics Service (7)
  9. Epidemiology and Biostatistics (7)
  10. Surgery (6)
Search Within
  1. "Michael Zelefsky"
  2. "Medical Physics"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (3)
  3. Conference Paper (1)
Groups
  1. Medical Physics (37)
  2. Radiation Oncology, Department of (37)
  3. Survivorship Research (37)
  4. Radiotherapy Physics Service (26)
  5. GDMT, Radiation Oncology (19)
  6. Gynecology Disease Management Team (19)

More Groups

People
  1. Michael Zelefsky (37)
  2. Gilad Cohen (28)
  3. Marisa Kollmeier (17)
  4. Yoshiya Yamada (17)
  5. Marco Zaider (15)
  6. Xin Pei (10)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2018 (1)
  5. 2017 (3)
  6. 2016 (3)

More Years

Publications
  1. Brachytherapy (29)
  2. Journal of Urology (3)
  3. Urology (3)
  4. European Urology (1)
  5. Magnetic Resonance Imaging (1)

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quantitative longitudinal mapping of radiation-treated prostate cancer using MR fingerprinting with radial acquisition and subspace reconstruction
    Journal Article

    Yu, V. Y.; Otazo, R.; Wu, C.; Subashi, E.; Baumann, M.; Koken, P.; Doneva, M.; Mazurkewitz, P.; Shasha, D.; Zelefsky, M.; more...
    Magnetic Resonance Imaging (2023)

    Fulltext@MSK | Save
  • Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost
    Journal Article

    Kollmeier, M. A.; Gorovets, D.; Flynn, J.; McBride, S.; Brennan, V.; Beaudry, J.; Cohen, G.; Damato, A.; Zhang, Z.; Zelefsky, M. J.
    Brachytherapy (2022)

    Fulltext@MSK | Save
  • Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer
    Journal Article

    Gorovets, D.; Hopkins, M.; Kollmeier, M.; Moore, A.; Goel, A.; Shasha, D.; Brennan, V.; McBride, S.; Cohen, G.; Damato, A. L.; more...
    Brachytherapy (2021)

    Fulltext@MSK | Save
  • Quantifying clinical severity of physics errors in high-dose rate prostate brachytherapy using simulations
    Journal Article

    Nunez, D. A.; Trager, M.; Beaudry, J.; Cohen, G. N.; Dauer, L. T.; Gorovets, D.; Hassan Rezaeian, N.; Kollmeier, M. A.; Leong, B.; McCann, P.; more...
    Brachytherapy (2021)

    Fulltext@MSK | Save
  • Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103
    Journal Article

    Taggar, A. S.; Charas, T.; Cohen, G. N.; Boonyawan, K.; Kollmeier, M.; McBride, S.; Mathur, N.; Damato, A. L.; Zelefsky, M. J.
    Brachytherapy (2018)

    Fulltext@MSK | Save
  • Changes in seed configuration within prostate with implantation of a hydrogel rectal spacer and Its impact on urethral dose
    Meeting Abstract

    Taggar, A. S.; Mathur, N.; Charas, T.; Cohen, G. N.; Mangal, S.; Kollmeier, M.; Zelefsky, M. J.; Damato, A. L.
    Brachytherapy (2017)

    Fulltext@MSK | Save
  • Day 0 dosimetric evaluation for LDR prostate brachytherapy may be superior to day 30 assessments by providing similar quality assurance information at earlier time points
    Meeting Abstract

    King, M. T.; Cohen, G. N.; Kollmeier, M. A.; Pei, X.; Damato, A. L.; Zelefsky, M. J.
    Brachytherapy (2017)

    Fulltext@MSK | Save
  • Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time
    Journal Article

    Kollmeier, M. A.; McBride, S.; Taggar, A.; Anderson, E.; Lin, M.; Pei, X.; Weiji, S.; Voros, L.; Cohen, G.; Yamada, Y.; more...
    Brachytherapy (2017)

    Fulltext@MSK | Save
  • Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy
    Journal Article

    King, M. T.; Nasser, N. J.; Mathur, N.; Cohen, G. N.; Kollmeier, M. A.; Yuen, J.; Vargas, H. A.; Pei, X.; Yamada, Y.; Zakian, K. L.; more...
    Brachytherapy (2016)

    Fulltext@MSK | Save
  • Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy
    Journal Article

    Nasser, N. J.; Cohen, G. N.; Dauer, L. T.; Zelefsky, M. J.
    Brachytherapy (2016)

    Fulltext@MSK | Save